Administration of 17-alpha-hydroxyprogestrone (17-OHP) via deep intramuscular injection
|
|
|
|
|
|
Administration of 17-OHP via subcutaneous autoinjector
|
|
|
|
|
|
Facilitating patient access to commercial 17-OHP
|
|
|
|
|
|
Counseling patients about the safety of aspirin use during pregnancy
|
|
|
|
|
|
Identifying patients who are candidates for aspirin use during pregnancy
|
|
|
|
|
|
Discussing postpartum contraception plans with pregnant patients
|
|
|
|
|
|
Determining which contraception methods are safe during postpartum and breastfeeding
|
|
|
|
|
|